Skip to main content
Blood logoLink to Blood
. 2014 May 8;123(19):3056. doi: 10.1182/blood-2014-04-567313

Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934.

PMCID: PMC4014847

On page 1923 in the 12 September 2013 issue, there was an error in the footer. The published ahead of print date reads, “Prepublished online as Blood First Edition paper, August 5, 2013.” The published ahead of print date should have read, “Prepublished online as Blood First Edition paper, August 7, 2013.” The error has been corrected in the online version, which now differs from the print version.


Articles from Blood are provided here courtesy of The American Society of Hematology

RESOURCES